What is it about?
After liberation, Bangladesh pharma industry was largely dominated by the import dependent MNCs. On or before 1982 ordinance, 75% of the market was dominated by the MNCs and the rest share was with the other 133 local companies. After NDP formulation and the Drug Control Ordinance, there was a dramatic change of reverse. By 1994, a few pharma companies achieved a tremendous growth and they reinvest their profit for faster return. By next decade, Bangladesh is aiming to 30 world class drug manufacturers to establish strong footstep in global pharma market. Bangladesh, as an LDC got exempted from the obligation of patent and data protection in this arena until 2033. Interestingly, Bangladesh already passed across the LDC landmark to a developing country. So, there’s window of opportunity of more than a decade to grow further from that aspect. Methodology: The research comprised a year-round comprehensive data collection from newspapers, journals, newsletters, news reports and updates. The true focus was on historical data collection, current market scenario, projections by experts in related fields, drug dealers, mergers and acquisitions, market trend analysis reports and newer development prospects. Findings: Bangladesh pharma market has tremendous hope, although going through lots of anomalies. Reasons behind are economic development, population blast, investment scopes, FDIs along with many other unexplained matters. Research limitations: Market is too big to be explained in a single article. The term “A -Z” doesn’t reveal all information about Bangladesh pharma market is accomplished, rather 26 letters used in 26 headlines, that means 26 points of this market is discussed that surely comprised a greater part of it. Practical Implication: The soul of this article was to introduce students about Bangladesh pharma market, that they have very few ideas. Along with students, researchers and professionals of different background and disciplines, e.g. Pharmacists, marketers, finance companies and regulatory authorities have to acquire much from this article. Social Implication: Medicine manufacturers are an integral part of Bangladesh health sector. General people pay much interest but having little knowledge about them. The article should provide them a broader picture and unleash many unseen facts.
Featured Image
Photo by Sharon McCutcheon on Unsplash
Read the Original
This page is a summary of: An A-Z Pharmaceutical Industry: Bangladesh Perspective, Asian Journal of Research in Pharmaceutical Sciences, January 2019, Diva Enterprises Private Limited,
DOI: 10.5958/2231-5659.2019.00004.3.
You can read the full text:
Resources
Local pharma market set to hit $5.11b by 2023
Bangladesh's pharmaceuticals sector will grow 15 percent year-on-year to reach $5.11 billion by 2023, propelled by high investments by local companies as they seek to grab a bigger share of the global market, said a new study yesterday.
Bangladesh Pharmaceutical Industry: Perspective and the Prospects
There are a good number of sectors in Bangladesh on which we feel much proud of, and undoubtedly the pharmaceutical sector is one of these best sectors. It is one of Bangladesh’s most success stories and one of the most technologically advanced dynamic sectors currently in existence. This industry is a matter of substantial pride to the country. Skillful attitudes, knowledge and innovative ideas from the Pharma Professionals are the key factors why this industry grew in the way it did. Imports are restricted by the Government of the People’s Republic of Bangladesh for locally manufactured drugs giving the industry protection from external competition. Drug Policy 1982 played a pivotal role in developing country’s own pharmaceutical industries.
Contributors
The following have contributed to this page